Literature DB >> 26745229

Patterns of Radiation-Associated Lymphopenia in Children with Cancer.

Miloš D Miljković1, Stuart A Grossman2, Xiaobu Ye2, Susannah Ellsworth3, Stephanie Terezakis3.   

Abstract

Adults with cancer commonly develop severe lymphopenia two months following chemoradiation therapy, which is an independent predictor of survival. In this retrospective study of 53 children with central nervous system tumors and sarcomas, the frequency, severity, and duration of radiation-associated lymphopenia was similar to that seen in adults. Pretreatment lymphocyte counts were 1,000 cells/mm(3) or greater in all patients, with 66% experiencing grade III-IV lymphopenia two months after chemoradiation. Lymphocyte counts remained significantly lower than baseline 12 months later. Further studies are needed to determine if this is also associated with poorer survival, as seen in adults.

Entities:  

Keywords:  Brain tumors; Lymphopenia; Radiation therapy; Sarcomas

Mesh:

Year:  2016        PMID: 26745229      PMCID: PMC4782785          DOI: 10.3109/07357907.2015.1086366

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  26 in total

1.  The effect of radiation therapy on lymphocyte subpopulations in cancer patients.

Authors:  M Raben; N Walach; U Galili; M Schlesinger
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

2.  Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay.

Authors:  N Nakamura; Y Kusunoki; M Akiyama
Journal:  Radiat Res       Date:  1990-08       Impact factor: 2.841

3.  The development of lymphopenia in uremic patients undergoing extracorporeal irradiation of the blood with portable beta units.

Authors:  E Weeke
Journal:  Radiat Res       Date:  1973-12       Impact factor: 2.841

Review 4.  T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review.

Authors:  C L Mackall
Journal:  Oncologist       Date:  1999

5.  Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.

Authors:  Michael A Hughes; Michele Parisi; Stuart Grossman; Lawrence Kleinberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-01       Impact factor: 7.038

6.  Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma.

Authors:  Guillermo De Angulo; Mike Hernandez; Jaime Morales-Arias; Cynthia E Herzog; Peter Anderson; Johannes Wolff; Eugenie S Kleinerman
Journal:  J Pediatr Hematol Oncol       Date:  2007-01       Impact factor: 1.289

7.  Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.

Authors:  P Lissoni; F Brivio; L Fumagalli; G Messina; V Ghezzi; L Frontini; L Giani; M Vaghi; A Ardizzoia; G S Gardani
Journal:  Int J Biol Markers       Date:  2004 Apr-Jun       Impact factor: 2.659

8.  The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study.

Authors:  G G Steinmann; B Klaus; H K Müller-Hermelink
Journal:  Scand J Immunol       Date:  1985-11       Impact factor: 3.487

9.  Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.

Authors:  Guillermo De Angulo; Carrie Yuen; Shana L Palla; Peter M Anderson; Patrick A Zweidler-McKay
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

10.  Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma.

Authors:  K Hiraoka; M Miyamoto; Y Cho; M Suzuoki; T Oshikiri; Y Nakakubo; T Itoh; T Ohbuchi; S Kondo; H Katoh
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

View more
  2 in total

1.  Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma.

Authors:  Clemens Grassberger; Daniel Shinnick; Beow Y Yeap; Mark Tracy; Susannah G Ellsworth; Clayton B Hess; Elizabeth A Weyman; Sara L Gallotto; Miranda P Lawell; Benjamin Bajaj; David H Ebb; Myrsini Ioakeim-Ioannidou; Jay S Loeffler; Shannon M MacDonald; Nancy J Tarbell; Torunn I Yock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-02-05       Impact factor: 8.013

2.  Pneumocystis jirovecii prophylaxis in patients treated for high-grade gliomas: a survey among neuro-oncologists.

Authors:  Nebojša Skorupan; Surabhi Ranjan; Seema Mehta; Olga Yankulina; Nathan Nenortas; Stuart Grossman; Xiaobu Ye; Matthias Holdhoff
Journal:  Neurooncol Pract       Date:  2018-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.